MacNeil D, Fraga E, Singh B
Department of Immunology, University of Alberta, Edmonton, Canada.
Eur J Immunol. 1992 Apr;22(4):937-41. doi: 10.1002/eji.1830220409.
T cells bearing certain variable (V) regions of the T cell receptor (TcR), including V beta 3, V beta 6, V beta 8.1 and V beta 9, are stimulated by one or more forms of the endogenous superantigen, mouse lymphocyte stimulatory (Mls) locus, encoded by the mouse mammary tumor virus, in the context of a non-polymorphic region of the class II molecules of the major histocompatibility complex (MHC). To identify putative sites of interaction of TcR-V beta region and Mls-1a, we examined the effect of peptides derived from the protein sequence of V beta 6 on recognition of Mls-1a by T cell hybridomas and show that three peptides corresponding to amino acid positions 1 to 20, 48 to 75, and 58 to 75 of the V beta 6 peptide sequence interfere with the activation of several V beta 6+ hybridomas by Mls-1a-bearing spleen cells, but not with that of a V beta 8+ hybridoma. The Mls-reactive hybridomas are specific for a synthetic peptide poly-18, poly EYK(EYA)5 and its peptide (EYA)5, in the context of I-Ad. This peptide does not require processing and the peptides 1-20, 48-75, and 58-75 do not inhibit recognition of (EYA)5 by the same V beta 6+ T cell hybridomas. The two sequences 1-20 and 58-75 are proposed to lie outside the putative binding domain of processed antigen, indicating that recognition by TcR of Mls-1a is different from the classical MHC-restricted recognition of processed antigen. These results suggest that the recognition of superantigen/class II MHC by T cells can be inhibited by peptides related to the site of interaction of the TcR, suggesting that such peptides could have possible regulatory effects on the induction and regulation of immune responses.
携带某些T细胞受体(TcR)可变(V)区的T细胞,包括Vβ3、Vβ6、Vβ8.1和Vβ9,在主要组织相容性复合体(MHC)II类分子的非多态性区域的背景下,被一种或多种内源性超抗原、由小鼠乳腺肿瘤病毒编码的小鼠淋巴细胞刺激(Mls)基因座所刺激。为了确定TcR-Vβ区与Mls-1a的假定相互作用位点,我们研究了源自Vβ6蛋白序列的肽对T细胞杂交瘤识别Mls-1a的影响,并表明与Vβ6肽序列的氨基酸位置1至20、48至75和58至75相对应的三种肽会干扰携带Mls-1a的脾细胞对几种Vβ6 +杂交瘤的激活,但不会干扰Vβ8 +杂交瘤的激活。Mls反应性杂交瘤在I-Ad的背景下对合成肽poly-18、聚EYK(EYA)5及其肽(EYA)5具有特异性。该肽不需要加工,而肽1-20、48-75和58-75不会抑制相同的Vβ6 + T细胞杂交瘤对(EYA)5的识别。序列1-20和58-75被认为位于加工后抗原的假定结合域之外,这表明TcR对Mls-1a的识别不同于经典的MHC限制性加工后抗原的识别。这些结果表明,T细胞对超抗原/II类MHC的识别可被与TcR相互作用位点相关的肽所抑制,这表明此类肽可能对免疫反应的诱导和调节具有潜在的调节作用。